
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
导演郑某峰猥亵儿童被刑拘,多名女演员发文控诉,律师:如属实会增加量刑
正观新闻客户端
缅甸妙瓦底电诈园区300名中国籍人员被遣返
@央视新闻
菲方闯入中国领空前关闭飞机信号!菲方擅闯黄岩岛领空细节曝光
玉渊谭天微博
四川检察机关依法对陈晏涉嫌受贿、滥用职权案提起公诉
央视新闻客户端
长沙一小区楼顶被种出茂密“丛林”,居民担心安全!城管:屋顶有产权,会上门查看
潇湘晨报
“事情已解决”房东猥亵女租客因超70岁不执行拘留,女子男友最新回应
大河报
缅方遣返111名妙瓦底园区中国籍人员
央视新闻
菲律宾飞机非法闯入中国南沙岛礁附近空域,南部战区发声
“南部战区”微信公众号
《哪吒2》“裂空爪”美甲爆火,老板称复刻至少千元以上,线上30元版本卖爆了
新闻晨报
耕耘春天
新华网